Home
Press releases
Press releases
Recent press, briefings and insights helping you stay informed on AliveDx newest launch.
-
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ’s Innovator’s Circle in partnership to improve patient care and laboratory efficiencies JERSEY, Channel Islands, 21 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a
-
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on a single multimodal multiplexing platform JERSEY, Channel Islands, 8 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered
-
Quotient Limited Launches Scientific Advisory Board and Research Programs
MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countries Quotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator Initiated
-
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
Received feedback from the European notified body after review of Expanded IH submission Pleased with feedback and expect to submit a response to the questions in the next couple of weeks Continue to expect approval in Q1 CY 2022
-
Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer
“It is my pleasure to welcome Esteban to the Executive team at this exciting time in our Company’s evolution. Esteban brings his experience in leading high-growth teams and unifying manufacturing and supply chain management. As we transition the company from
-
Quotient Limited Announces Appointment of Chief Financial Officer
“I am delighted to welcome Ali to the Executive team at this exciting time in our Company’s evolution. He brings over 20 years of experience in global finance and has been a key driver of operational excellence in a career
-
Quotient Limited Announces Appointment of Chief Commercial Officer
“I am delighted to welcome a strong and experienced commercial leader like Mohammad to the Executive team. During the last 30 years, he has been partnering with customers across the globe. Mohammad will be instrumental in accelerating the commercialization of
-
Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray
JERSEY, Channel Islands, 1 October 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of the Expanded Immunohematology (IH) technical file dossier for review by the European notified
-
MosaiQ by Quotient Wins Prestigious Red Dot Design Award
MosaiQ is designed to deliver rapid immunohematology, serological and molecular disease screening, using a single low volume sample on a high throughput, multimodal multiplexing automated platform. MosaiQ represents a transformative and potentially highly disruptive unified testing system for transfusion diagnostics
-
Quotient Limited Announces Manuel Mendez as Chief Executive Officer
“We are very confident, that Manuel is the right leader”, said Heino von Prondzynski, Chairman of Quotient’s Board of Directors. “His background and experience make him ideally suited to guide the Company through its very important next phase, commercialization of
